Mohand Iberrakene
About Mohand Iberrakene
Mohand Iberrakene is the Directeur Stratégique Commerciale de Zone Oncologie at Bristol-Myers Squibb, specializing in cardiology within oncology and operating in Hauts-de-France and Normandie.
Current Role at Bristol-Myers Squibb
Mohand Iberrakene currently holds the position of Directeur Stratégique Commerciale de Zone Oncologie at Bristol-Myers Squibb. He operates primarily in the Hauts de France and Normandie regions, bringing over 19 years of experience within the company to his role. His responsibilities include formulating strategies for the commercial development of oncology products, with a specialized focus on cardiology within the oncology sector.
Past Experience at AstraZeneca
Before joining Bristol-Myers Squibb, Mohand Iberrakene served as Directeur ventes régionales at AstraZeneca from 2000 to 2004. During his four-year tenure in the Hauts-de-France region, he was instrumental in managing regional sales activities. This role provided him with extensive experience in oversight, strategy implementation, and team management within the pharmaceutical sales domain.
Education at Universite de Lille 1
Mohand Iberrakene is an alumnus of Universite de Lille 1, where he earned a Maîtrise de Biochimie. His academic background in biochemistry has laid a solid foundation for his professional career in the pharmaceutical industry, particularly in strategic commercial roles focused on oncology and cardiology.
Specialization in Cardiology within Oncology
In his current role at Bristol-Myers Squibb, Mohand Iberrakene specializes in cardiology within the broader field of oncology. This specific focus allows him to contribute to the strategic growth of the company's oncology portfolio, using insights and expertise from both disciplines to drive commercial success.
Working Regions: Hauts-de-France and Normandie
Mohand Iberrakene operates within the geographical regions of Hauts-de-France and Normandie. His familiarity with these areas, combined with his significant industry experience, enables him to effectively execute his responsibilities as Directeur Stratégique Commerciale de Zone Oncologie at Bristol-Myers Squibb.